Zentalis Pharmaceuticals, Inc.
$341.09M- Market cap
- $292.42M
- Debt
- +$82.57M
- Cash
- −$33.90M
Capital structure 78% equity / 22% debt · EV / Revenue 5.06x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ZNTL · price snapshotP/S 4.34x
$4.08Snapshot Sep 8, 2026, 1:58 PM ET
Implied fair value · at RPD's multiple
$0.7880.9% below market
0.94 ZNTL revenue / share×0.83x RPD P/S=$0.78
Market $4.08Implied $0.78
RPD · price snapshotP/S 0.83x
$10.59Snapshot Sep 8, 2026, 1:59 PM ET
Implied fair value · at ZNTL's multiple
$55.32422.4% above market
12.76 RPD revenue / share×4.34x ZNTL P/S=$55.32
Market $10.59Implied $55.32